翻訳と辞書 |
Gavilimomab
Gavilimomab (also known as ABX-CBL) is a mouse monoclonal antibody intended for use as an immunosuppressive biologic treatment of glucocorticoid-resistant graft versus host disease. It binds to the antigen CD147.〔 Gavilimomab proved slightly less effective than standard antithymocyte globulin therapy. It was originally developed by Abgenix,〔(findarticles.com: Sangstat to Provide Clinical Development Update At JP Morgan H&Q Conference in San Francisco )〕 which was later acquired by Amgen. ==References==
抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「Gavilimomab」の詳細全文を読む
スポンサード リンク
翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|